EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E)

Luca Zambelli, Ernesto Zecca, Gabriele Tinè, Claudia Giani, Sandro Pasquali, Laura Monteleone, Martina Maserati, Lorenzo D'Ambrosio, Andrea Vanzulli, Anna Maria Frezza, Denise Robinson, Hugh Leonard und 8 weitere

European Journal of Cancer · 2026-11 · 248 · 117769

DOI: 10.1016/j.ejca.2026.117769 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Luca Zambelli und 19 weiteren Autor:innen. Beteiligte Einrichtung: Palliative Care - Hospice Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Hemangioendothelioma, Epithelioid, Pain Measurement, Cancer Pain. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Epithelioid hemangioendothelioma (EHE) is an ultra-rare sarcoma with heterogeneous behavior. Tumor-related pain is a clinically relevant symptom in advanced disease. We report the first prospective evaluation of pain in EHE, its incidence and prognostic significance, and the development of EHE-tailored Pain Assessment Criteria (PAC-E) framework. METHODS: From March 2021, patients with molecularly confirmed EHE were enrolled in the POEM study, a prospective, multicentric, international observational study (NCT06680401). Tumor-related pain was assessed using a numerical rating scale (NRS), with worst pain intensity (WPI) used for analysis. Clinically relevant pain was defined as WPI > 4. Pain characteristics, serosal involvement, analgesic response, and overall survival (OS) were evaluated. PAC-E were developed by integrating longitudinal pain changes and analgesic use, based on POEM data and a targeted literature review. RESULTS: Among 54 patients with advanced EHE enrolled by June 2025, 15 (27.8%) experienced tumor-related pain and 13 (24%) had WPI> 4. Pain was predominantly nociceptive and associated with pleural involvement (n = 7). High-potency NSAIDs were effective in patients with pleural pain and limited opioid response. WPI> 4 was associated with shorter OS compared with WPI≤ 4 (p < 0.001). PAC-E was derived from these observations. CONCLUSIONS: Moderate-to-severe tumor-related pain affected approximately one quarter of patients with advanced EHE and was associated with poorer survival. Its predominance as nociceptive pain and association with serosal involvement support its role as a clinically relevant marker of disease aggressiveness. PAC-E provides disease-specific criteria for standardized pain assessment, pending validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemangioendothelioma, EpithelioidPain MeasurementCancer PainHumansFemaleMaleProspective StudiesMiddle AgedAgedAdultPrognosis

Stichwörter der Autor:innen

Epithelioid hemangioendotheliomaPainPain evaluationPrognosisSarcomaSurvival

Autor:innen und Institutionen

  • Palliative Care - Hospice Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Medical Oncology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Molecular Pharmacology, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Clinical Trials Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Oncology, University of Turin, San Luigi Gonzaga University Hospital, Turin, Italy.
  • Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Förderung

  • Ministero della Salute
  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Zambelli, L., Zecca, E., Tinè, G., Giani, C., Pasquali, S., Monteleone, L., Maserati, M., D'Ambrosio, L., Vanzulli, A., Frezza, A. M., Robinson, D., Leonard, H., Pantziarka, P., Tap, W. D., Jones, R. L., Taverna, S., Chen, T. W., Caraceni, A., Miceli, R., & Stacchiotti, S. (2026). Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E). European Journal of Cancer, 248, 117769. https://doi.org/10.1016/j.ejca.2026.117769

Vancouver

Zambelli L, Zecca E, Tinè G, Giani C, Pasquali S, Monteleone L, et al. Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E). European Journal of Cancer. 2026;248:117769. doi:10.1016/j.ejca.2026.117769

BibTeX
@article{Zambelli2026,
  author = {Zambelli, Luca and Zecca, Ernesto and Tinè, Gabriele and Giani, Claudia and Pasquali, Sandro and Monteleone, Laura and Maserati, Martina and D'Ambrosio, Lorenzo and Vanzulli, Andrea and Frezza, Anna Maria and Robinson, Denise and Leonard, Hugh and Pantziarka, Pan and Tap, William D and Jones, Robin L and Taverna, Silvia and Chen, Tom Wei-Wu and Caraceni, Augusto and Miceli, Rosalba and Stacchiotti, Silvia},
  title = {Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E)},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117769},
  doi = {10.1016/j.ejca.2026.117769}
}
Kostenlos starten →